Skip to content

Pharmacology, Biochemistry, and Behavior

ISSN 1873-5177, 0091-3057

325 papers in the library · 3,738 citations · publishing 1975-2026

Papers

Sort Most recent Most cited

MDMA produces a conditioned place preference and elicits ejaculation in male rats: a modulatory role for the endogenous opioids.

Pharmacology, Biochemistry, and Behavior October 1, 1991 E J Bilsky, C L Hubbell, J D Delconte et al.

Methylenedioxymethamphetamine (MDMA) can produce a conditioned place preference (CPP) among rats. The ability of MDMA to produce a CPP was assessed while some rats were under the influence of naltrexone, 56 mg/kg, given 4 h before conditioning. Naltrexone attenuated MDMA's ability to produce a CPP without completely blocking MDMA's effects. Having noticed previously the production of seminal...

DOI: 10.1016/0091-3057(91)90577-o (opens in new tab) Animals Rats, inbred strains N-methyl-3,4-methylenedioxyamphetamine Naltrexone +8

3,4-Methylenedioxyamphetamine (MDA) self-administration and neurotoxicity.

Pharmacology, Biochemistry, and Behavior July 1991 L E Markert, D C Roberts

3,4-Methylendioxyamphetamine (MDA), a drug with both stimulant- and hallucinogen-like properties, has been used for both medical and recreational purposes. The present study examined the reinforcing effects of MDA in rats and evaluated the resulting neurotoxicity. Self-administration of various doses (0.10, 0.05 and 0.025 mg/injection) was examined on a Fixed Ratio 1 (FR1) and a Progressive...

The neurochemical and stimulatory effects of putative metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in rats.

Pharmacology, Biochemistry, and Behavior July 1991 S Y Yeh, F L Hsu

Rats were injected SC with a dose of 10 mg/kg (as base) of 3,4-methylenedioxyamphetamine (MDA), or 3,4-methylenedioxymethamphetamine (MDMA), 4-hydroxy-3-methoxyamphetamine, alpha-methyldopamine and alpha-methylnorepinephrine, metabolites of MDA, and alpha-methylepinephrine, a putative metabolite of MDMA, twice daily for either 5 or 7 consecutive doses. The rats were killed 24 h after the last...

The effects of repeated administration of MDMA on the expression of sexual behavior in the male rat.

Pharmacology, Biochemistry, and Behavior July 1, 1991 W A Dornan, J L Katz, George A. Ricaurte

3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") is a potent neurotoxin which preferentially produces 5-HT nerve terminal degeneration in the CNS in both rodents and primates. Timely research on the behavioral effects of acute and long term treatment of MDMA is critical due to the neuropathological effects of MDMA and its abuse liability. Presently, there are no published reports that have...

DOI: 10.1016/0091-3057(91)90171-w (opens in new tab) Serotonin Hippocampus Corpus striatum Animals +8

Effects of MDA on classical conditioning of the rabbit nictitating membrane response.

Pharmacology, Biochemistry, and Behavior May 1991 K Kirkpatrick-Steger, S Vander Linden, I Gormezano

In Experiment 1, classical conditioning of the rabbit's nictitating membrane response (NMR) was accomplished by pairing tone and light conditioned stimuli (CSs) with a shock unconditioned stimulus (UCS). MDA impaired the acquisition of conditioned responses (CR) to a tone-CS, while significantly enhancing CR acquisition to a light-CS. Experiment 2, employing explicitly unpaired CS, UCS...

3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine.

Pharmacology, Biochemistry, and Behavior March 1991 D J McKenna, X M Guan, Alexander T. Shulgin

The effect of various analogues of the neurotoxic amphetamine derivative, MDA (3,4-methylenedioxyamphetamine) on carrier-mediated, calcium-independent release of 3H-5-HT and 3H-DA from rat brain synaptosomes was investigated. Both enantiomers of the neurotoxic analogues MDA and MDMA (3,4-methylenedioxymethamphetamine) induce synaptosomal release of 3H-5-HT and 3H-DA in vitro. The release of...

Assessment of the role of alpha-methylepinine in the neurotoxicity of MDMA.

Pharmacology, Biochemistry, and Behavior February 1991 T D Steele, W K Brewster, M P Johnson et al.

To assess the potential involvement of metabolism of 3,4-methylenedioxymethamphetamine (MDMA) to the catechol alpha-methylepinine in producing serotonergic neurotoxicity, we attempted to correlate aspects of this reaction with the neurotoxicity profile of MDMA. In contrast to the stereoselectivity of S-(+)-MDMA in causing persistent declines in rat brain 5-hydroxyindole levels, no...

Opposite effects of 5-methoxy-N,N-di-methyl-tryptamine and 5-hydroxytryptophan on male rat sexual behavior.

Pharmacology, Biochemistry, and Behavior 1991 S Ahlenius, K Larsson 31 citations

The administration of 5-methoxy-N,N-di-methyl-tryptamine (5-MeODMT), O-2.0 mg.kg-1 SC -15 min, produced a dose-dependent facilitation of the male rat sexual behavior, as evidenced by a decrease in the number of intromissions to ejaculation and in the ejaculation latency. The effects produced by 5-MeODMT (1 mg.kg-1) were antagonized by pindolol (4 mg.kg-1 SC -30 min), but not pirenperone (0.25...

Do functional relationships exist between 5-HT1A and 5-HT2 receptors?

Pharmacology, Biochemistry, and Behavior August 1, 1990 N A Darmani, B R Martin, U Pandey et al. 245 citations

To investigate the possible functional relationship between 5-HT1 and 5-HT2 receptors, we studied the effects of a nonselective 5-HT agonist (5-MeO DMT), a 5-HT1A-selective (8-OH-DPAT) and a 5-HT1B/5-HT1C-selective (TFMPP) agonist on the head-twitch behavior induced by the putative 5-HT2-selective receptor agonist (+/-)-DOI. In the mouse (+/-)-DOI produced the head-twitch response in a...

Delayed effects of amphetamine or phencyclidine: interaction of food deprivation, stress and dose.

Pharmacology, Biochemistry, and Behavior July 1990 J R Coveney, S B Sparber

Tritium-labelled phencyclidine (PCP) hydrochloride (12 mg/kg) was injected SC for six consecutive days into two groups of eight male rats maintained at 85% of their initial free-feeding weights. Eight days after the last injection, electric footshock raised fat levels of PCP 28% over nonshocked controls, and lowered blood levels 18%, but did not alter brain levels of the drug significantly....

Behavioral reactivity following 5-MeODMT administration in 5,7-DHT-pretreated killer rats.

Pharmacology, Biochemistry, and Behavior June 1, 1990 G R Cuadra, V A Molina 4 citations

Grouped, nonkiller and killer animals were centrally injected either with vehicle or with 5,7-dihydroxytryptamine. After a period of 7-10 days, forepaw treading and hindlimb abduction were induced by 5-MeODMT administration in all sham and lesioned rats. As expected, behavioral supersensitivity was observed in grouped and nonkiller lesioned rats. A reduced increase in 5-MeODMT-induced behaviors...

Acute interactive pharmacologic effects of inhaled toluene and dichloromethane on rat brain electrophysiology.

Pharmacology, Biochemistry, and Behavior June 1990 C S Rebert, M J Matteucci, G T Pryor

Toluene (TOL) and dichloromethane (DCM) are widely used industrial solvents and are common components of solvent mixtures that are voluntarily inhaled to produce altered states of consciousness. In previous studies we characterized some of the acute electrophysiologic effects of these solvents. Opposite effects were noted for some measures, suggesting that they might be antagonistic when...

Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine and methylenedioxyamphetamine.

Pharmacology, Biochemistry, and Behavior March 1990 James P Zacny, R M Virus, William L. Woolverton

The effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) (0.62-20.0 mg/kg), (+)-methamphetamine (MA) (0.62-5.0 mg/kg) and (+/-)-3,4-methylenedioxyamphetamine (MDA) (0.62-5.0 mg/kg) on milk intake in rats were determined before and during a period of repeated daily administration of MDMA. Experimental sessions consisted of 15-min access to a sweetened milk solution each day, 5 days a week....

[125I]-2-(2,5-dimethoxy-4-iodophenyl)aminoethane ([125I]-2C-I) as a label for the 5-HT2 receptor in rat frontal cortex.

Pharmacology, Biochemistry, and Behavior 1990 M P Johnson, C A Mathis, Alexander T. Shulgin et al. 56 citations

Recent studies of 5-HT2 receptor binding have involved the use of radiolabeled agonists. This report describes the use of [125I]-2-(2,5-dimethoxy-4-iodophenyl)aminoethane ([125I]-2C-I) as a label for low-density 5-HT2 agonist binding sites. A nonhydrolyzable analog of GTP, GppNHp, was found to inhibit the high affinity binding of [125I]-2C-I. 5-HT and several 5-HT2 agonists and antagonists...

Studies of dioxole ring substituted 3,4-methylenedioxyamphetamine (MDA) analogues.

Pharmacology, Biochemistry, and Behavior November 1989 D E Nichols, Robert Oberlender, K Burris et al.

The 3,4-ethylidenedioxy and 3,4-isopropylidenedioxy analogues, EDA and IDA, respectively, of 3, 4-methylenedioxyamphetamine (MDA) were compared to MDA in drug-stimulated [3H]-serotonin overflow from prelabelled rat hippocampal slices, [3H]-dopamine overflow from prelabelled rat caudate slices, in their ability to displace the 5-HT2 agonist R-[125I]-DOI from rat brain cortical binding sites....

Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance.

Pharmacology, Biochemistry, and Behavior September 1989 S J Heishman, M L Stitzer, J E Yingling

This study investigated the smoking topography of marijuana and its effect on heart rate, subjective reports, and cognitive/psychomotor task performance. Male subjects (N = 12) with histories of moderate marijuana use smoked ad lib one cigarette containing 0, 1.3, or 2.7% delta 9-THC on separate days. Smoking topography measures revealed smaller puff and inhalation volumes and shorter puff...

Selective cross-tolerance to 5-HT1A and 5-HT2 receptor-mediated temperature and corticosterone responses.

Pharmacology, Biochemistry, and Behavior August 1, 1989 J F Nash, Herbert Y. Meltzer, Gary A. Gudelsky 40 citations

The repeated administration of 5-methoxy-N,N-dimethyltryptamine (5-MeODMT, 3 mg/kg, twice daily for 14 days) significantly diminished hypothermia and corticosterone secretion induced by an acute challenge with the 5-HT1A agonist 8-OH-DPAT (0.1 mg/kg) when compared to the responses in animals treated chronically with the solvent vehicle. In contrast, the chronic administration of 5-MeODMT did...

Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline.

Pharmacology, Biochemistry, and Behavior August 1989 Richard A Glennon, B R Misenheimer

Tests of stimulus generalization were conducted using rats trained to discriminate 1.5 mg/kg of N-monomethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane HCl (MDMA) from saline in order to determine if two structurally related analogs (MDE and N-OH MDA) would produce similar stimulus effects. The MDMA-stimulus (MDMA, ED50 value = 0.76 mg/kg) generalized both to MDE (ED50 value = 0.73 mg/kg) and...

Tripelennamine interactions with the psychotomimetic sigma agonist N-allylnormetazocine.

Pharmacology, Biochemistry, and Behavior July 1989 D B Vaupel

The pharmacological effects of individual and combined intravenous doses of the antihistamine tripelennamine and the psychotomimetic sigma benzomorphan opioid derivative, N-allylnormetazocine (NANM), on nociceptive reflexes, autonomic parameters and behavior were assessed in the chronic spinal dog. NANM (1.65 mg/kg, IV) produced antinociception, mydriasis, tachycardia, hyperthermia and...

Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats.

Pharmacology, Biochemistry, and Behavior July 1989 A A Li, Gerard J. Marek, Georgetta Vosmer et al.

The behavioral effect of single administration of +/- 3,4-methylene-dioxymethamphetamine (MDMA) on rats performing on the differential-reinforcement-of-low-rate 72-second schedule (DRL 72-sec) was compared before and after a period of repeated administration of MDMA known to deplete 5-hydroxytryptamine (5-HT) levels in the brain. Single administration of MDMA decreased reinforcement rate (1, 2,...

The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) on stereotyped behavior in rats.

Pharmacology, Biochemistry, and Behavior June 1989 M Hiramatsu, Toshitaka Nabeshima, T Kameyama et al.

The relative potencies of S(+)-, R(-)-3,4-methylenedioxymethamphetamine (MDMA) and S(+)-methylene-dioxyamphetamine (MDA) in inducing stereotyped behavior were determined in comparison with p-chloroamphetamine. S(+)-MDMA was more potent than R(-)-MDMA in eliciting stereotyped behaviors such as sniffing, head-weaving, backpedalling and turning and wet-dog shakes. These results are consistent with...

Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration.

Pharmacology, Biochemistry, and Behavior May 1, 1989 M P Johnson, D E Nichols 26 citations

The possible neurotoxic effects of the alpha-ethyl homologue of MDMA, N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB), were examined following a regimen of twice daily dosing for four days. The levels of norepinephrine, serotonin and its metabolite 5-HIAA were quantitated by standard HPLC-EC techniques. In addition, the number of 5-HT uptake sites was estimated by examining the binding of...

Effects of intraocular mescaline and LSD on visual-evoked responses in the rat

Pharmacology, Biochemistry, and Behavior 1989 Janis T. Eells, Douglas M. Wilkison 10 citations

The effects of mescaline and LSD on the flash-evoked cortical potential (FEP) were determined in unrestrained rats with chronically-implanted electrodes. Systemic administration of mescaline or LSD significantly attenuated the primary component of the FEP at three stimulus intensities with the greatest effect observed 60-90 minutes following drug administration. The magnitude and specificity of...

Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

Pharmacology, Biochemistry, and Behavior December 1988 M D Schechter

A series of three experiments were conducted to investigate the possible serotonergic and dopaminergic mediation of the discriminative stimulus properties of the "designer" drug MDMA. In Experiment 1, rats trained to discriminate 1.5 mg/kg (+/-)-MDMA from its vehicle at 20 min postadministration were shown to generalize to another drug of abuse, N-ethyl-3,4-methylenedioxyamphetamine (MDE) and...

Alcohol and marijuana: comparative dose effect profiles in humans.

Pharmacology, Biochemistry, and Behavior November 1988 S J Heishman, M L Stitzer, G E Bigelow

This study compared subjective and performance dose effect profiles of oral alcohol and smoked marijuana. Male subjects (N = 6) with histories of moderate alcohol and marijuana use received three doses of alcohol (0, 0.6, 1.2 g/kg) and three doses of marijuana (0, 1.3, 2.7% delta 9-THC) in a double-blind, randomized crossover design. Physiological indices indicated that active drug was...